Moderna, Inc.
Overview
Moderna, Inc. is listed on Nasdaq and classified as Biological Products, (No Diagnostic Substances). We have no business description beyond that classification; its SEC filings describe the business.
| Information | Status | As of |
|---|---|---|
| Detailed research report | No report | |
| Rule-based screens | Scored, on no current shortlist | 2026-10-31 |
| Valuation | None | |
| Chart-pattern read | No read | |
| Paper portfolio | Never held |
Scores
| Method | Score | Inputs as of | Flags |
|---|---|---|---|
| Graham Defensive | 38 | 2025-12-31 | partial, missing 5 stale input |
| Magic Formula | n/a | ||
| Momentum | 83 | 2026-10-30 | |
| Insider | 0 | 2026-10-30 | |
| Buffett Quality | 10 | 2026-07-24 | |
| Lynch GARP | 32 | 2026-06-30 | stale input |
| Graham Enterprising | 36 | 2026-06-30 | stale input |
| Piotroski F-Score | 22 |
Every input with its filing: full score sheet · research packet (JSON) · Markdown · SEC filings.